Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2008European Journal of Nuclear Medicine and Molecular ImagingOpen Access

Chemotherapy response assessment in stage IV melanoma patients—comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B

View Full Paper
Ask AI
Bookmark
Share

Authors

KSKlaus StrobelUniversity of LucerneReinhard DummerReinhard DummerAstraZeneca (United Kingdom)HSHans C. SteinertKlinik Hirslanden

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Strobel et al. (2008) studied this question.

synapsesocial.com/papers/6a72024d75498292b70b47d9https://doi.org/10.1007/s00259-008-0806-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The chemoresistance of human malignant melanoma1999 · 142 citations
  2. 2Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients2006 · 274 citations
  3. 3Pulmonary metastatic melanoma — the survival benefit associated with positron emission tomography scanning2002 · 59 citations
  4. 4Role of Positron Emission Tomography in Lymphoma2005 · 115 citations